Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases

• Published in: Journal of Neural Transmission Vol. 127; no. 1; pp. 27 - 34
• Main Authors: Le Nogue, Déborah, Lavaur, Jérémie, Milet, Aude, Ramirez-Gil, Juan Fernando, Katz, Ira, Lemaire, Marc, Farjot, Géraldine, Hirsch, Etienne C., Michel, Patrick Pierre
• Format: Journal Article
• Language: English
• Published: Vienna Springer Vienna 01.01.2020; Springer Verlag
• Subjects: Animals; Carboxylic Acids - pharmacology; Cells, Cultured; Dopaminergic Neurons - drug effects; Embryo, Mammalian; Excitatory Amino Acid Antagonists - pharmacology; Female; Helium - pharmacology; Human health and pathology; Krypton - pharmacology; Life Sciences; Medicine; Medicine & Public Health; Memantine - pharmacology; Mesencephalon; Neon - pharmacology; Neurology; Neurology and Preclinical Neurological Studies - Original; Neurology and Preclinical Neurological Studies - Original Article; Neuroprotective Agents - administration & dosage; Neuroprotective Agents - pharmacology; Neurosciences; Psychiatry; Pyridines - pharmacology; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors; Xenon - administration & dosage; Xenon - pharmacology; Noble gases; Parkinson disease; Neurodegeneration; Excitotoxicity; Dopamine neurons; Xenon
• ISSN: 0300-9564; 1435-1463
• DOI: 10.1007/s00702-019-02112-x

Using midbrain cultures, we previously demonstrated that the noble gas xenon is robustly protective for dopamine (DA) neurons exposed to l - trans -pyrrolidine-2,4-dicarboxylate (PDC), an inhibitor of glutamate uptake used to generate sustained, low-level excitotoxic insults. DA cell rescue was observed in conditions where the control atmosphere for cell culture was substituted with a gas mix, comprising the same amount of oxygen (20%) and carbon dioxide (5%) but 75% of xenon instead of nitrogen. In the present study, we first aimed to determine whether DA cell rescue against PDC remains detectable when concentrations of xenon are progressively reduced in the cell culture atmosphere. Besides, we also sought to compare the effect of xenon to that of other noble gases, including helium, neon and krypton. Our results show that the protective effect of xenon for DA neurons was concentration-dependent with an IC 50 estimated at about 44%. We also established that none of the other noble gases tested in this study protected DA neurons from PDC-mediated insults. Xenon’s effectiveness was most probably due to its unique capacity to block NMDA glutamate receptors. Besides, mathematical modeling of gas diffusion in the culture medium revealed that the concentration reached by xenon at the cell layer level is the highest of all noble gases when neurodegeneration is underway. Altogether, our data suggest that xenon may be of potential therapeutic value in Parkinson disease, a chronic neurodegenerative condition where DA neurons appear vulnerable to slow excitotoxicity.